Ascletis Pharma, Inc. (HK:1672) has released an update.
Ascletis Pharma Inc. has scheduled a Board meeting on August 30, 2024, to discuss and approve their interim financial results for the first half of the year, and to consider the declaration of an interim dividend. This meeting will be critical for shareholders and potential investors as it may influence the company’s stock performance based on the financial outcomes and dividend decisions.
For further insights into HK:1672 stock, check out TipRanks’ Stock Analysis page.
